SPY414.92-5.67 -1.35%
DIA332.96-5.20 -1.54%
IXIC14,030.38-130.97 -0.92%

Adamas Pharmaceuticals Q1 EPS $(0.36) Beats $(0.51) Estimate, Sales $19.30M Miss $20.02M Estimate

Adamas Pharmaceuticals (NASDAQ:ADMS) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.51) by 29.41 percent. This is a 38.98 percent increase over losses of $(0.59) per share

05/10/2021 16:25
Adamas Pharmaceuticals (NASDAQ:ADMS) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.51) by 29.41 percent. This is a 38.98 percent increase over losses of $(0.59) per share from the same period last year. The company reported quarterly sales of $19.30 million which missed the analyst consensus estimate of $20.02 million by 3.60 percent. This is a 33.28 percent increase over sales of $14.48 million the same period last year.